Middlefield Canadian Income PCC: Net Asset Value(s)

Click here - to use the wp menu builder

News Room

Less than 1 min.Read

By Investing Today

October 9, 2024

Middlefield Canadian Income PCC Net Asset Value

Middlefield Canadian Income PCC

Middlefield Canadian Income – GBP PC
(a protected cell company incorporated in Jersey with registration number 93546)
Legal Entity Identifier: 2138007ENW3JEJXC8658

Net Asset Value

As at the close of business on 08 October 2024 the estimated unaudited Net Asset Value per share was 135.18 pence (including accrued income).

Investments in the Company’s portfolio have been valued on a bid price basis.

Enquiries:

JTC Fund Solutions (Jersey) Limited
01534 700 000

Hot this week

Topics

Popular Categories

News RoomFeatured CompaniesVideos

Summary of Bigbank AS Webinar Introducing the Public Subordinated Bond Offering

Awilco Drilling PLC: Notice of Extraordinary General Meeting

Middlefield Canadian Income PCC: Net Asset Value(s)

Cash flows (CK94) – Nykredit Realkredit A/S

Cash flows (CK94) – Totalkredit A/S

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 30 09 2024

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Fortuna reports solid production of 110,820 gold equivalent ounces for the third quarter of 2024

Topics

Cash flows (CK94) – Nykredit Realkredit A/S

Cash flows (CK94) – Totalkredit A/S

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 30 09 2024

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Fortuna reports solid production of 110,820 gold equivalent ounces for the third quarter of 2024

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Net Asset Value(s)

Major shareholder

Related Articles

Cash flows (CK94) – Nykredit Realkredit A/S

Cash flows (CK94) – Totalkredit A/S

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 30 09 2024

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Fortuna reports solid production of 110,820 gold equivalent ounces for the third quarter of 2024

Company

Headlines

Cash flows (CK94) – Nykredit Realkredit A/S

Cash flows (CK94) – Totalkredit A/S

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 30 09 2024

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Newsletter